Loading clinical trials...
Loading clinical trials...
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT06299540 · Leukemia, Lymphocytic, Chronic, B-Cell
NCT00131014 · Non-Hodgkin's Lymphoma, Hodgkin's Disease, and more
NCT07162181 · Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, and more
NCT02869529 · Leukemia, Lymphocytic, Chronic, B-Cell
NCT05424822 · Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions